January - March 2017, Volume 13, Issue 1

Usta Atmaca H, Akbas F

Is Salusin-Alpha a New Marker of Cardiovascular Disease Risk in Hypothyroidism?

Acta Endo (Buc) 2017, 13 (1): 53-59
doi: 10.4183/aeb.2017.53

Introduction. Salusins are multifunctional endogenous peptides shown in human and rat tissues. Serum salusin α level is decreased in coronary artery disease and lack of salusin α enhances coronary atherosclerosis. Hypothyroidism is a chronic inflammatory disease that has a high risk of developing cardiovascular disease. Here we aimed to search the relationship of overt hypothyroidism and subclinical hypothyroidism with salusin α and other inflammatory markers, also the effect of L-thyroxine treatment on these findings. Material and Methods. 32 patients with overt hypothyroidism taking L-thyroxine treatment, 18 patients with subclinical hypothyroidism without treatment and 25 healthy patients as control group were included in the study. Serum salusin α, TNF α, sCRP, glucose, insulin and lipid levels were tested for all groups and results were evaluated with SPSS statistical analysis method. Results. HDL, sCRP, salusin mean values were statistically significantly different in all 3 groups. HDL level was statistically significantly higher in control group compared to treatment group. sCRP level was higher and salusin level was lower in both treatment and non-treatment hypothyroidism groups compared to control group. When treatment and non-treatment hypothyroidism groups were compared, there was no statistically significant difference for salusin α, but HDL level was high and insulin level was low statistically significant in treatment group. Conclusions. Salusin α that is shown to be protective for coronary artery disease and hypertension, is found to be significantly low in hypothyroidism, thus it is a marker that increases the cardiovascular disease risk in this specific patient group.

Keywords: Salusins, hypothyroidism, cardiometabolic risk, inflammation.

Correspondence: Hanife Usta Atmaca MD, Istanbul Training and Research Hospital, Dept. of Internal Medicine, Samatya, Istanbul, 34000, Turkey, E-mail: hanifeusta@yahoo.com